BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30683825)

  • 1. The influence of orlistat, metformin and diet on serum levels of insulin-like growth factor-1 in obeses women with and without insulin resistance.
    Kujawska-Luczak M; Szulinska M; Skrypnik D; Musialik K; Swora-Cwynar E; Kregielska-Narozna M; Markuszewski L; Grzymislawska M; Bogdanski P
    J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of serum adiponectin and leptin concentrations: effects of a low-calorie or isocaloric diet combined with metformin or orlistat - a prospective randomized open-label trial.
    Kargulewicz A; Szulińska M; Kujawska-Łuczak M; Swora-Cwynar E; Musialik K; Grzymisławska M; Kręgielska-Narożna M; Bogdański P
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3868-3876. PubMed ID: 27735028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
    Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.
    Swora-Cwynar E; Kujawska-Łuczak M; Suliburska J; Reguła J; Kargulewicz A; Kręgielska-Narożna M; Marcinkowska E; Kanikowska A; Bielas M; Grzymisławski M; Bogdański P
    Acta Sci Pol Technol Aliment; 2016; 15(2):213-220. PubMed ID: 28071011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women.
    Sari R; Balci MK; Coban E; Yazicioglu G
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1059-63. PubMed ID: 15211369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
    Bougoulia M; Triantos A; Koliakos G
    Hormones (Athens); 2006; 5(4):259-69. PubMed ID: 17178701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
    Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
    Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women.
    Di Somma C; Rivellese A; Pizza G; Patti L; De Rosa A; Cipriano P; Nedi V; Rossi A; Lombardi G; Colao A; Savastano S
    J Endocrinol Invest; 2011 Feb; 34(2):90-6. PubMed ID: 21502796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of aerobic exercise plus diet control on serum levels of total IGF-1 and IGF-1 binding protein-3 in female obese youths and adolescents].
    Yang HF; Lin XJ; Wang XH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):78-82. PubMed ID: 29926665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An RCT of metformin versus orlistat for the management of obese anovulatory women.
    Metwally M; Amer S; Li TC; Ledger WL
    Hum Reprod; 2009 Apr; 24(4):966-75. PubMed ID: 19095663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study.
    Kujawska-Łuczak M; Musialik K; Szulińska M; Swora-Cwynar E; Kargulewicz A; Grzymisławska M; Pupek-Musialik D; Bogdański P
    Arch Med Sci; 2017 Jun; 13(4):725-731. PubMed ID: 28721138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; D'Angelo A; Fogari E; Palumbo I; Randazzo S; Cicero AF
    Expert Opin Pharmacother; 2010 Aug; 11(12):1971-82. PubMed ID: 20569086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children.
    Jaksic M; Martinovic M; Gligorovic-Barhanovic N; Antunovic T; Nedovic-Vukovic M
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):301-309. PubMed ID: 33618443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.